Physician profile
Jaime Vasquez
NPI 1629091301
$5,171.11
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.17 · 2021: $64.16 · 2022: $40.09 · 2024: $5,037.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $5,037.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $5,036.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vitrolife INC. | $5,036.69 | 2024 | |
| Ferring Pharmaceuticals INC. | $34.98 | 2019-2022 | |
| Hologic Sales and Service, LLC | $23.71 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $21.56 | 2022 | |
| Coopersurgical, INC. | $20.46 | 2021 | |
| Abbvie INC. | $19.99 | 2021 | |
| Vertical Pharmaceuticals, LLC | $13.72 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Vasquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.